financetom
Business
financetom
/
Business
/
Bezos' Blue Origin to layoff about 10% across its space, launch business
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bezos' Blue Origin to layoff about 10% across its space, launch business
Feb 13, 2025 7:42 AM

WASHINGTON (Reuters) -The CEO of Jeff Bezos' Blue Origin announced in an all-hands call on Thursday company-wide layoffs of "about 10 percent" of its employees, a sweeping readjustment of its space and launch business.

The layoffs affect roughly 1,400 of the company's nearly 14,000 employees and comes as Blue Origin aims to ramp up production of its giant New Glenn rocket, which had its first long-awaited debut launch last month.

"We just came to the painful conclusion that we aren't set up for the kind of success that we really wanted to have," Dave Limp told employees in the meeting announcing the layoffs.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Agnico Eagle Mines Invests $2.9 Million in Maple Gold Mines
Agnico Eagle Mines Invests $2.9 Million in Maple Gold Mines
Jun 24, 2024
08:32 AM EDT, 06/24/2024 (MT Newswires) -- Agnico Eagle Mines ( AEM ) said on Monday that it bought about 33.8 million Maple Gold Mines ( MGMLF ) common shares on June 21 at $0.085 apiece for about $2.9 million. The sellers had acquired the shares in connection with an offering of flow-through common shares issued by Maple. Agnico Eagle...
GSK Says Omjjara Approved in Japan to Treat Myelofibrosis
GSK Says Omjjara Approved in Japan to Treat Myelofibrosis
Jun 24, 2024
08:32 AM EDT, 06/24/2024 (MT Newswires) -- GSK (GSK) said in a regulatory filing Monday that Japan's Ministry of Health, Labour and Welfare has approved Omjjara for the treatment of myelofibrosis, a rare blood cancer. The approval was based on data from the Momentum and Simplify-1 pivotal phase 3 trials, GSK said in a 6-K filing with the US Securities...
Alithya Group CFO to Depart; Interim Replacement Named
Alithya Group CFO to Depart; Interim Replacement Named
Jun 24, 2024
08:36 AM EDT, 06/24/2024 (MT Newswires) -- Alithya Group ( ALYAF ) said Monday that Claude Thibault is stepping down as chief financial officer of the company to pursue other endeavours. The company has tapped Debbie Di Gregorio to serve as interim chief financial officer, effective June 28. Di Gregorio joined Alithya ( ALYAF ) in October 2018 as vice...
Byrna Technologies Names Lauri Kearnes CFO
Byrna Technologies Names Lauri Kearnes CFO
Jun 24, 2024
08:32 AM EDT, 06/24/2024 (MT Newswires) -- Byrna Technologies ( BYRN ) said Monday it has named Lauri Kearnes as chief financial officer, effective July 15. The company said Kearnes, who will succeed retiring CFO David North, was most recently the finance chief at Harte Hanks ( HHS ) . Shares of Byrna ( BYRN ) were 1.4% higher in...